MECHANISMS OF VERAPAMIL INHIBITION OF BRONCHOSPASM
MECHANISMS OF VERAPAMIL INHIBITION OF BRONCHOSPASM
批准号:
3343525
负责人:
GILBERT A RINARD
金额:
$6.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1987-03-31
关键词:
aerosols allergens antiadrenergic agents antiallergic agents antihistamines asthma bronchospasm disease /disorder model drug interactions drug metabolism helminthic antigen high performance liquid chromatography nerve endings neural transmission neuropharmacology parasympathetic nervous system pentobarbital reflex respiratory airway pressure respiratory muscles verapamil
中文摘要
我们已经证明维拉帕米能够消除抗原诱导的
支气管痉挛 与此相反,维拉帕米仅能有效地减弱
组胺引起的气道阻力最大增加。 这些发现
对药物的作用机制有重要影响,
维拉帕米,提示主要作用于除气道通畅以外的部位
肌肉.
本项目的总体目标是确定主要的行动方式
异搏定影响犬哮喘模型的支气管收缩。
本研究的第一个目的是确定维拉帕米是否能抑制
组胺的释放和其他可能的立即
超敏反应 在蛔虫期间将采集动脉血样本
猪抗原(阿萨)气溶胶激发过敏犬前后
维拉帕米治疗 血清组胺水平将通过高
压力液相色谱法和/或化学分析法。
第二个目的是确定迷走神经反射是否在神经系统的病理生理过程中起主要作用。
我们的过敏性支气管收缩模型 双侧迷走神经阻滞
在阿萨和组胺支气管激发期间产生。 此外该
戊巴比妥麻醉的效果将通过进行对照检查
使用氯醛糖作为主要麻醉剂的实验。
第三个目的是检验维拉帕米可以抑制
乙酰胆碱从副交感神经节和神经末梢内释放
气道平滑肌 将进行频率/响应测量
在电场刺激离体气管肌条时,
维拉帕米的存在与否
英文摘要
We have demonstrated verapamil's ability to abolish antigen-induced
bronchospasm. In contrast, verapamil was effective in only attenuating the
maximal increase in airway resistance induced by histamine. These findings
have important implications concerning the mechanism of action of
verapamil, suggesting major action at a site other than airway smooth
muscle.
The overall goal of this project is to determine the major mode of action
of verapamil as it affects bronchoconstriction in a canine asthma model.
The first aim of this study will be to determine if verapamil can inhibit
the release of hisamine and perhaps other mediators of immediate
hypersensitivity. Arterial blood samples will be collected during Ascaris
suum antigen (ASA) aerosol challenges of allergic dogs before and after
verapamil treatment. Serum histamine levels will be determined by high
pressure liquid chromatography and/or by chemical assay.
The second aim will be to determine if vagal reflexes play a major role in
our model of allergic bronchoconstriction. Bilateral vagal blockade will
be produced during ASA and histamine bronchoprovocation. In addition, the
effects of pentobarbital anesthesia will be examined by conducting control
experiments in which chloralose is utilized as the primary anesthetic agent.
The third aim will be a test of the hypothesis that verapamil can inhibit
acetylcholine release from parasympathetic ganglia and nerve endings within
the airway smooth muscle. Frequency/response measurements will be made
during electrical field stimulation of trachealis muscle strips in vitro in
the presence and absence of verapamil.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
-
批准号:3344235
-
项目类别:
-
资助金额:$10.14万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
-
批准号:3344234
-
项目类别:
-
资助金额:$15.24万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
MECHANISMS OF VERAPAMIL INHIBITION OF BRONCHOSPASM
-
批准号:3343526
-
项目类别:
-
资助金额:$5.64万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
-
批准号:3344238
-
项目类别:
-
资助金额:$14.93万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
-
批准号:3344237
-
项目类别:
-
资助金额:$15.58万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
-
批准号:3344236
-
项目类别:
-
资助金额:$9.91万
-
财政年份:1984
-
负责人:GILBERT A RINARD
-
依托单位:
海外基金